Bioneer Statistics
Total Valuation
Bioneer has a market cap or net worth of KRW 491.17 billion. The enterprise value is 465.80 billion.
Market Cap | 491.17B |
Enterprise Value | 465.80B |
Important Dates
The next estimated earnings date is Tuesday, March 18, 2025.
Earnings Date | Mar 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Bioneer has 25.81 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 25.81M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 15.80% |
Owned by Institutions (%) | 8.41% |
Float | 21.71M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 12.26 |
PS Ratio | 1.71 |
PB Ratio | 2.34 |
P/TBV Ratio | 2.39 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -17.47 |
EV / Sales | 1.62 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -30.26 |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.32.
Current Ratio | 2.40 |
Quick Ratio | 1.73 |
Debt / Equity | 0.32 |
Debt / EBITDA | n/a |
Debt / FCF | -4.66 |
Interest Coverage | -4.72 |
Financial Efficiency
Return on equity (ROE) is -10.07% and return on invested capital (ROIC) is -3.07%.
Return on Equity (ROE) | -10.07% |
Return on Assets (ROA) | -2.73% |
Return on Capital (ROIC) | -3.07% |
Revenue Per Employee | 511.85M |
Profits Per Employee | -47.43M |
Employee Count | 562 |
Asset Turnover | 0.88 |
Inventory Turnover | 1.75 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.50% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -37.50% |
50-Day Moving Average | 21,468.00 |
200-Day Moving Average | 27,984.75 |
Relative Strength Index (RSI) | 41.62 |
Average Volume (20 Days) | 120,424 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioneer had revenue of KRW 287.66 billion and -26.66 billion in losses. Loss per share was -1,032.73.
Revenue | 287.66B |
Gross Profit | 215.22B |
Operating Income | -14.25B |
Pretax Income | -16.89B |
Net Income | -26.66B |
EBITDA | -5.17B |
EBIT | -14.25B |
Loss Per Share | -1,032.73 |
Balance Sheet
The company has 111.08 billion in cash and 71.68 billion in debt, giving a net cash position of 39.40 billion or 1,526.66 per share.
Cash & Cash Equivalents | 111.08B |
Total Debt | 71.68B |
Net Cash | 39.40B |
Net Cash Per Share | 1,526.66 |
Equity (Book Value) | 223.92B |
Book Value Per Share | 8,132.12 |
Working Capital | 98.10B |
Cash Flow
In the last 12 months, operating cash flow was -11.90 billion and capital expenditures -3.49 billion, giving a free cash flow of -15.39 billion.
Operating Cash Flow | -11.90B |
Capital Expenditures | -3.49B |
Free Cash Flow | -15.39B |
FCF Per Share | -596.31 |
Margins
Gross margin is 74.82%, with operating and profit margins of -4.96% and -9.27%.
Gross Margin | 74.82% |
Operating Margin | -4.96% |
Pretax Margin | -5.87% |
Profit Margin | -9.27% |
EBITDA Margin | -1.80% |
EBIT Margin | -4.96% |
FCF Margin | n/a |
Dividends & Yields
Bioneer does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -5.43% |
FCF Yield | -3.13% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Bioneer has an Altman Z-Score of 5.24.
Altman Z-Score | 5.24 |
Piotroski F-Score | n/a |